Elomaa I - Search Results

1

Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapy.

Elomaa I, Taube T, Blomqvist C, Rissanen P, Rannikko S, Alfthan O. Elomaa I, et al. Eur Urol. 1988;14(2):104-6. doi: 10.1159/000472913. Eur Urol. 1988. PMID: 3360030

2

Hormone-resistant metastatic prostate cancer. Comparisons between estramustine phosphate and low-dose epirubicin treatments.

Elomaa I, Kellokumpu-Lehtinen P, Rannikko S, Alfthan O. Elomaa I, et al. Eur Urol. 1991;19(1):12-5. Eur Urol. 1991. PMID: 1706666 Clinical Trial.

3

Clodronate for osteolytic metastases due to breast cancer.

Elomaa I, Blomqvist C, Porkka L, Holmström T, Taube T, Lamberg-Allardt C, Borgström GH. Elomaa I, et al. Biomed Pharmacother. 1988;42(2):111-6. Biomed Pharmacother. 1988. PMID: 2971403 Clinical Trial.

4

Aminoglutethimide as second line therapy in advanced breast cancer.

Elomaa I, Blomqvist C, Rissanen P. Elomaa I, et al. Breast Cancer Res Treat. 1986;7 Suppl:S51-4. Breast Cancer Res Treat. 1986. PMID: 3017481

5

Weekly low-dose doxorubicin as second line therapy in advanced breast cancer.

Elomaa I, Blomqvist C, Rissanen P. Elomaa I, et al. Acta Oncol. 1988;27(6b):799-801. doi: 10.3109/02841868809094360. Acta Oncol. 1988. PMID: 3233165

6

Bisphosphonate therapy in metastatic breast cancer.

Blomqvist C, Elomaa I. Blomqvist C, et al. Among authors: elomaa i. Acta Oncol. 1996;35 Suppl 5:81-3. doi: 10.3109/02841869609083977. Acta Oncol. 1996. PMID: 9142974 Review.

7

Postirradiation sarcoma. Analysis of a nationwide cancer registry material.

Wiklund TA, Blomqvist CP, Räty J, Elomaa I, Rissanen P, Miettinen M. Wiklund TA, et al. Among authors: elomaa i. Cancer. 1991 Aug 1;68(3):524-31. doi: 10.1002/1097-0142(19910801)68:3<524::aid-cncr2820680313>3.0.co;2-e. Cancer. 1991. PMID: 2065271

8

Treatment of skeletal disease in breast cancer: a controlled clodronate trial.

Elomaa I, Blomqvist C, Porkka L, Lamberg-Allardt C, Borgström GH. Elomaa I, et al. Bone. 1987;8 Suppl 1:S53-6. Bone. 1987. PMID: 2961355 Clinical Trial.

9

Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trial.

Elomaa I, Blomqvist C, Rissanen P, Mäntylä M. Elomaa I, et al. Acta Oncol. 1988;27(3):297-9. doi: 10.3109/02841868809093543. Acta Oncol. 1988. PMID: 2970862 Clinical Trial. No abstract available.

10

Evaluation of salmon calcitonin treatment in bone metastases from breast cancer--a controlled trial.

Blomqvist C, Elomaa I, Porkka L, Karonen SL, Lamberg-Allardt C. Blomqvist C, et al. Among authors: elomaa i. Bone. 1988;9(1):45-51. doi: 10.1016/8756-3282(88)90026-9. Bone. 1988. PMID: 3288258 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters